| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| D N Ruskin, D A Bergstrom, Y Kaneoke, B N Patel, M J Twery, J R Walter. Multisecond oscillations in firing rate in the basal ganglia: robust modulation by dopamine receptor activation and anesthesia. Journal of neurophysiology. vol 81. issue 5. 1999-06-14. PMID:10322046. |
the modulation of multisecond periodicities in firing rate by dopaminergic agonists suggests the involvement of these patterns in behaviors and cognitive processes that are affected by dopamine. |
1999-06-14 |
2023-08-12 |
rat |
| A Rinken, S Ferré, A Terasmaa, C Owman, K Fux. Serotonergic agonists behave as partial agonists at the dopamine D2 receptor. Neuroreport. vol 10. issue 3. 1999-06-10. PMID:10208577. |
there were no significant differences between the maximal effects seen in activation of [35s]gtpgammas binding caused by dopaminergic agonists, but the effects of 5-ht, 8oh-dpat and 5-methoxytryptamine amounted to 47 +/- 7%, 43 +/- 5% and 70 +/- 7% of the dopamine effect, respectively. |
1999-06-10 |
2023-08-12 |
rat |
| M A Piggott, E F Marshall, N Thomas, S Lloyd, J A Court, E Jaros, D Costa, R H Perry, E K Perr. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine. Neuroscience. vol 90. issue 2. 1999-06-10. PMID:10215149. |
dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of d1 and d2 but not of d3 receptor binding or dopamine. |
1999-06-10 |
2023-08-12 |
human |
| C Cadoni, G Di Chiar. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience. vol 90. issue 2. 1999-06-10. PMID:10215150. |
in this model, we investigated the changes produced by repeated morphine treatment on dopamine transmission at the level of the two major terminal dopaminergic areas, the dorsolateral caudate-putamen and the nucleus accumbens in its two subdivisions, the shell and the core. |
1999-06-10 |
2023-08-12 |
rat |
| J Booij, T G Hemelaar, J D Speelman, K de Bruin, A G Janssen, E A van Roye. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. vol 40. issue 5. 1999-06-08. PMID:10319746. |
parkinson's disease is characterized by degeneration of dopaminergic neurons, resulting in loss of dopamine transporters in the striatum. |
1999-06-08 |
2023-08-12 |
Not clear |
| M Diana, M Melis, G L Gess. Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids. The European journal of neuroscience. vol 10. issue 9. 1999-06-07. PMID:9758152. |
considering that supranormal stimulation of d1 dopamine receptors in the prefrontal cortex has been shown to impair working memory, the present results suggest that the negative effects of cannabinoids on cognitive processes might be related to the activation of dopaminergic transmission in the prefrontal cortex. |
1999-06-07 |
2023-08-12 |
Not clear |
| I Date, T Ohmot. Neural transplantation for Parkinson's disease. Cellular and molecular neurobiology. vol 19. issue 1. 1999-06-04. PMID:10079966. |
grafted adrenal medullary chromaffin cells can provide dopamine as well as several neurotrophic factors that affect dopaminergic neurons in the brain. |
1999-06-04 |
2023-08-12 |
Not clear |
| A C McCreary, S L Handle. The thyrotrophin-releasing hormone analogue MK771 induces tic-like behaviours: the effects of dopamine D1 and D2 receptor antagonists. European journal of pharmacology. vol 369. issue 1. 1999-06-03. PMID:10204674. |
changes in spontaneous blinking frequency are observed in several disease states with dopamine abnormalities and dopaminergic agents modulate blinking. |
1999-06-03 |
2023-08-12 |
Not clear |
| L Kantor, G H Hewlett, M E Gneg. Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 19. issue 10. 1999-06-01. PMID:10234012. |
to examine the requirement for dopaminergic vesicles in the ca2+-dependent dopamine release, we administered reserpine to saline- and amphetamine-pretreated rats 1 d before killing. |
1999-06-01 |
2023-08-12 |
rat |
| A R Burkey, E Carstens, L Jasmi. Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 19. issue 10. 1999-06-01. PMID:10234044. |
injection of the dopamine reuptake inhibitor gbr-12935 in the rostral agranular insular cortex (raic), a cortical area that receives a dense dopaminergic projection and is involved in descending antinociception (burkey et al.,1996), resulted in dose-dependent inhibition of formalin-induced nociceptive behavior, without any alteration of motor function. |
1999-06-01 |
2023-08-12 |
rat |
| T L Sills, A J Greenshaw, G B Baker, P J Fletche. Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction. Psychopharmacology. vol 141. issue 4. 1999-05-28. PMID:10090650. |
serotonin shares on overlapping distribution with dopamine and has been shown to modulate dopaminergic function and dopamine-mediated behaviors. |
1999-05-28 |
2023-08-12 |
Not clear |
| G B Thomas, C J Phelps, I C Robinso. Differential regulation of hypothalamic tuberoinfundibular dopamine neurones in two dwarf rat models with contrasting changes in pituitary prolactin. Journal of neuroendocrinology. vol 11. issue 3. 1999-05-28. PMID:10201819. |
tgr rats also show reduced pituitary prolactin (prl), which may reflect an additional lactogenic feedback action of the hgh transgene, analogous to that in mice transgenic for peripheral hgh which show enhanced dopamine (da) and tyrosine hydroxylase (th) expression in the hypothalamic tuberoinfundibular dopaminergic (tida) neurones that inhibit prl secretion. |
1999-05-28 |
2023-08-12 |
mouse |
| M Morissette, M Goulet, R Grondin, P Blanchet, P J Bédard, T Di Paolo, D Lévesqu. Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies. The European journal of neuroscience. vol 10. issue 8. 1999-05-26. PMID:9767387. |
we also studied the effect of administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp) and chronic d1-like (skf 82958) or d2-like (cabergoline) agonist treatments on dopamine d3 receptor levels using receptor autoradiography. |
1999-05-26 |
2023-08-12 |
rat |
| J D Jentsch, J R Taylor, D E Redmond, J D Elsworth, K D Youngren, R H Rot. Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys. Psychopharmacology. vol 142. issue 1. 1999-05-26. PMID:10102786. |
d4 dopamine receptors (drs) are enriched in the primate prefrontal cortex, a brain region implicated in cognitive processes, and mesoprefrontal dopaminergic systems appear to be involved in modulating some cognitive functions of the prefrontal cortex. |
1999-05-26 |
2023-08-12 |
human |
| Y Bozzi, E Borrell. Absence of the dopamine D2 receptor leads to a decreased expression of GDNF and NT-4 mRNAs in restricted brain areas. The European journal of neuroscience. vol 11. issue 4. 1999-05-20. PMID:10103122. |
at the level of the substantia nigra, ntfs have been proposed to control dopamine release by regulating the firing rate of dopaminergic cells. |
1999-05-20 |
2023-08-12 |
mouse |
| Y Bozzi, E Borrell. Absence of the dopamine D2 receptor leads to a decreased expression of GDNF and NT-4 mRNAs in restricted brain areas. The European journal of neuroscience. vol 11. issue 4. 1999-05-20. PMID:10103122. |
thus, an interaction between the signalling cascades activated by ntfs and dopamine receptors might possibly influence the physiology of dopaminergic neurons. |
1999-05-20 |
2023-08-12 |
mouse |
| Y Bozzi, E Borrell. Absence of the dopamine D2 receptor leads to a decreased expression of GDNF and NT-4 mRNAs in restricted brain areas. The European journal of neuroscience. vol 11. issue 4. 1999-05-20. PMID:10103122. |
among dopamine receptors, d2 receptors (d2r) are the most abundant on dopaminergic neurons, where they exert autoreceptor functions. |
1999-05-20 |
2023-08-12 |
mouse |
| H Sershen, A Hashim, A Lajth. Gender differences in kappa-opioid modulation of cocaine-induced behavior and NMDA-evoked dopamine release. Brain research. vol 801. issue 1-2. 1999-05-12. PMID:9729284. |
it was then examined whether dopamine release, measured in vitro, plays a role in sex dependent differences in kappa-opioid- or nmda-modulated dopaminergic function. |
1999-05-12 |
2023-08-12 |
mouse |
| E Melamed, G Friedberg, J Zolda. Psychosis: impact on the patient and family. Neurology. vol 52. issue 7 Suppl 3. 1999-05-10. PMID:10227605. |
levodopa or dopamine agonist toxicity can lead to psychosis because of dopaminergic hypersensitivity. |
1999-05-10 |
2023-08-12 |
Not clear |
| M Legault, R A Wis. Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens. Synapse (New York, N.Y.). vol 31. issue 4. 1999-05-07. PMID:10051104. |
thus, the present study suggests that the modulation of dopaminergic neurotransmission by the ventral subiculum results from a trans-synaptic activation of dopamine cell bodies in the vta. |
1999-05-07 |
2023-08-12 |
Not clear |